Showing results (381-390 of 498) with videos related to
Sort By:
Pageof 50
Journal of Molecular Biology|February 8, 2011
Effects of the known pathogenic mutations on the aggregation pathway of the amyloidogenic peptide of apolipoprotein A-ISara Raimondi, Fulvio Guglielmi, Sofia Giorgetti, et al.Basic Research in Cardiology|August 29, 2013
Stanniocalcin1 is a key mediator of amyloidogenic light chain induced cardiotoxicityJian Guan, Shikha Mishra, Jianru Shi, et al.Circulation|December 28, 2018
Effects of Patisiran, an RNA Interference Therapeutic, on Cardiac Parameters in Patients With Hereditary Transthyretin-Mediated AmyloidosisScott D Solomon, David Adams, Arnt Kristen, et al.Blood Advances|July 6, 2021
Search for AL amyloidosis risk factors using Mendelian randomizationCharlie N Saunders, Subhayan Chattopadhyay, Stefanie Huhn, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 22, 2013
International Myeloma Working Group recommendations for the treatment of multiple myeloma-related bone diseaseEvangelos Terpos, Gareth Morgan, Meletios A Dimopoulos, et al.Analytical Chemistry|March 4, 2026
Current Standards and Perspectives in Proteomics for Cardiac AmyloidosisFrancesco Greco, Ellen McPhail, Diana Canetti, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 19, 2006
Characteristics and outcome of diffuse large B-cell lymphoma in hepatitis C virus-positive patients in LNH 93 and LNH 98 Groupe d'Etude des Lymphomes de l'Adulte programsCaroline Besson, Danielle Canioni, Eric Lepage, et al.Clinical Lymphoma & Myeloma|April 14, 2009
Balancing risk versus benefit in the treatment of Waldenström's Macroglobulinemia patients with nucleoside analogue-based therapyXavier Leleu, Jérome Tamburini, Aldo Roccaro, et al.Blood|October 25, 2003
Second cancers and late toxicities after treatment of aggressive non-Hodgkin lymphoma with the ACVBP regimen: a GELA cohort study on 2837 patientsMarc André, Nicolas Mounier, Xavier Leleu, et al.Blood|February 11, 2003
Rituximab plus CHOP (R-CHOP) overcomes bcl-2--associated resistance to chemotherapy in elderly patients with diffuse large B-cell lymphoma (DLBCL)Nicolas Mounier, Josette Briere, Christian Gisselbrecht, et al.Pageof 50